| 4th Nov 2024 4:36 pm |
RNS |
Response to media speculation |
| 10th Sep 2024 7:00 am |
RNS |
Interim results for the six months ended 30 June |
| 18th Jul 2024 3:52 pm |
RNS |
Grant of share options |
| 16th Jul 2024 7:00 am |
RNS |
Half-Year Trading Update |
| 3rd Jul 2024 1:16 pm |
RNS |
Holding(s) in Company |
| 24th Jun 2024 4:12 pm |
RNS |
Holding(s) in Company |
| 18th Jun 2024 5:15 pm |
RNS |
Exercise of Options, Director Dealing and TVR |
| 14th Jun 2024 7:00 am |
RNS |
Building purchase |
| 25th Apr 2024 2:27 pm |
RNS |
Result of AGM |
| 10th Apr 2024 7:15 am |
EQS |
Hardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth |
| 5th Apr 2024 3:52 pm |
RNS |
Holding(s) in Company |
| 19th Mar 2024 7:00 am |
RNS |
Final results for the year ended 31 December 2023 |
| 1st Mar 2024 7:00 am |
RNS |
Notice of Results |
| 6th Feb 2024 7:00 am |
RNS |
First EU shipment & new distributor agreements |
| 29th Jan 2024 3:02 pm |
RNS |
Holding(s) in Company |
| 25th Jan 2024 7:00 am |
RNS |
Trading update for 2023 |
| 23rd Jan 2024 5:24 pm |
RNS |
2023 LTIP Grant |
| 22nd Nov 2023 4:36 pm |
RNS |
Holding(s) in Company |
| 30th Oct 2023 7:00 am |
RNS |
HPRA approval & distribution agreement in Spain |
| 18th Sep 2023 10:40 am |
EQS |
Hardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23 |
| 15th Sep 2023 4:30 pm |
RNS |
Director/PDMR Shareholding |
| 5th Sep 2023 7:01 am |
RNS |
New sports medicine product launch |
| 5th Sep 2023 7:00 am |
RNS |
Interim results |
| 31st Aug 2023 1:45 pm |
RNS |
Exercise of Options and Total Voting Rights |
| 21st Aug 2023 7:00 am |
RNS |
Notice of interim results |
| 17th Jul 2023 7:00 am |
RNS |
Half-Year Trading Update |
| 10th Jul 2023 7:00 am |
RNS |
Distribution agreement for OrthoPure® XT in the UK |
| 25th May 2023 7:00 am |
RNS |
Distribution agreement with Australian Allografts |
| 9th May 2023 12:00 pm |
RNS |
Holding(s) in Company |
| 27th Apr 2023 12:35 pm |
RNS |
Result of AGM, Share Reorganisation &TVR |
| 18th Apr 2023 7:00 am |
RNS |
Proposed Share Reorganisation Timetable |
| 5th Apr 2023 2:55 pm |
EQS |
Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative |
| 5th Apr 2023 7:00 am |
RNS |
CEO and CFO Share Purchases |
| 30th Mar 2023 7:00 am |
RNS |
Holding(s) in Company |
| 21st Mar 2023 7:00 am |
RNS |
Final results for the year ended 31 December 2022 |
| 6th Mar 2023 7:00 am |
RNS |
Notice of results and Investor presentation |
| 31st Jan 2023 7:01 am |
RNS |
Trading update for 2022 |
| 31st Jan 2023 7:00 am |
RNS |
Change of Adviser |
| 18th Jan 2023 10:06 am |
RNS |
Holding(s) in Company |
| 18th Jan 2023 7:00 am |
RNS |
Chinese distribution agreement for OrthoPure® XT |
